We appreciate the interest of Dagogo-Jack (1) in our study of genetic ancestry and HbA1c in African Americans (2). We interpret his major concerns as follows: 1) HbA1c values may have a glucose-independent genetic component and 2) in our study, adjustment for glucose did not fully account for HbA1c values ≥6.5%.

Our goal was to evaluate if differences in genetic ancestry might explain differences in HbA1c between individuals of African and European ancestry observed in previous studies. Although the heritability of HbA1c approaches 60% in twin studies (3) and “glucose-independent” genetic loci for HbA1c have been found in populations of European descent (4), our results indicate that genetic loci accounting for the heritability of HbA1c are not likely to be population-specific or have large population differences.

After accounting for fasting glucose, we observed a prevalence of undiagnosed diabetes of 4.4% defined by HbA1c ≥6.5% (2), but as in prior studies, including that cited by Dagogo-Jack (5), adjustment for glucose was based on a single measurement and should be distinguished from average glucose (6). The within-person variability of a single glucose measurement is substantially higher than that of HbA1c (7). Thus, we cannot conclude that individuals shifted from the diabetes to the nondiabetes category in our analysis had normal glucose homeostasis. Single HbA1c and glucose measures communicate different information about glucose homeostasis in an individual. The availability of only a single glucose measure is a limitation of many epidemiological studies of glucose homeostasis, and the discrepancy between measures alone does not establish HbA1c as an inferior test.

We agree that our analyses cannot provide a definitive explanation for the black-white difference in HbA1c, but we feel strongly that there is little to suggest a strong genetic ancestral determinant of this difference. Our results support current recommendations for the use of HbA1c to diagnose diabetes in all ethnic groups (8).

No potential conflicts of interest relevant to this article were reported.

1.
Dagogo-Jack
S
.
Comment on: Maruthur et al. Does genetic ancestry explain higher values of glycated hemoglobin in African Americans?
Diabetes
2011
;
60
:
2434
2438
(Letter). Diabetes 2012;61:e1. DOI: 10.2337/db11-1277
2.
Maruthur
NM
,
Kao
WH
,
Clark
JM
, et al
.
Does genetic ancestry explain higher values of glycated hemoglobin in African Americans?
Diabetes
2011
;
60
:
2434
2438
3.
Snieder
H
,
Sawtell
PA
,
Ross
L
,
Walker
J
,
Spector
TD
,
Leslie
RD
.
HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins
.
Diabetes
2001
;
50
:
2858
2863
4.
Soranzo
N
,
Sanna
S
,
Wheeler
E
, et al
;
WTCCC
.
Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways
.
Diabetes
2010
;
59
:
3229
3239
5.
Herman
WH
,
Ma
Y
,
Uwaifo
G
, et al
;
Diabetes Prevention Program Research Group
.
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program
.
Diabetes Care
2007
;
30
:
2453
2457
6.
Nathan
DM
,
Turgeon
H
,
Regan
S
.
Relationship between glycated haemoglobin levels and mean glucose levels over time
.
Diabetologia
2007
;
50
:
2239
2244
7.
Selvin
E
,
Crainiceanu
CM
,
Brancati
FL
,
Coresh
J
.
Short-term variability in measures of glycemia and implications for the classification of diabetes
.
Arch Intern Med
2007
;
167
:
1545
1551
8.
American Diabetes Association
.
Standards of medical care in diabetes—2011
.
Diabetes Care
2011
;
34
(
Suppl. 1
)
S11
S61
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.